Effect of ebastine on serum eosinophil cationic protein levels in patients with bronchial asthma

OBJECTIVE. This study evaluated the effects of ebastine on serum eosinophil cationic protein (ECP) levels in patients with bronchial asthma. PATIENTS. Twenty patients with bronchial asthma and low efficiency of current therapy (11 patients with atopic disease and 9 with non-atopic disease) were enro...

Full description

Bibliographic Details
Main Authors: T. Horiguchi, S. Tachikawa, J. . Kasahara, Y. . Sasaki, M. . Hirose, M. . Shiga, R. Kondo, J. Miyazaki, M. . Sugiyama
Format: Article
Language:Russian
Published: Remedium Group LLC 2013-12-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/1144
_version_ 1797841236299612160
author T. Horiguchi
S. Tachikawa
J. . Kasahara
Y. . Sasaki
M. . Hirose
M. . Shiga
R. Kondo
J. Miyazaki
M. . Sugiyama
author_facet T. Horiguchi
S. Tachikawa
J. . Kasahara
Y. . Sasaki
M. . Hirose
M. . Shiga
R. Kondo
J. Miyazaki
M. . Sugiyama
author_sort T. Horiguchi
collection DOAJ
description OBJECTIVE. This study evaluated the effects of ebastine on serum eosinophil cationic protein (ECP) levels in patients with bronchial asthma. PATIENTS. Twenty patients with bronchial asthma and low efficiency of current therapy (11 patients with atopic disease and 9 with non-atopic disease) were enrolled in the study. METHODS. In an open-label design, all patients received ebastine 10 mg/day for 4 weeks and serum ECP levels, peripheral blood eosinophil counts, morning peak expiratory flow rate (PEFR) and thresholds for airway hyper-responsiveness (Dmin in asthgraphy) were determined before and after treatment. RESULTS. Serum ECP levels and peripheral blood eosinophil counts were significantly decreased. No significant change was found in the non-atopic patients, while the serum ECP level was significantly (p
first_indexed 2024-04-09T16:28:54Z
format Article
id doaj.art-af2ee2e7d2d34e5e983b70311bcc159d
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:28:54Z
publishDate 2013-12-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-af2ee2e7d2d34e5e983b70311bcc159d2023-04-23T06:57:13ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902013-12-01011384310.21518/2079-701X-2013-11-38-431144Effect of ebastine on serum eosinophil cationic protein levels in patients with bronchial asthmaT. Horiguchi0S. Tachikawa1J. . Kasahara2Y. . Sasaki3M. . Hirose4M. . Shiga5R. Kondo6J. Miyazaki7M. . Sugiyama8Department of Respiratory Diseases, Second Hospital for Medical Education, Fujita Health University of MedicineDepartment of Respiratory Diseases, Second Hospital for Medical Education, Fujita Health University of MedicineDepartment of Respiratory Diseases, Second Hospital for Medical Education, Fujita Health University of MedicineDepartment of Respiratory Diseases, Second Hospital for Medical Education, Fujita Health University of MedicineDepartment of Respiratory Diseases, Second Hospital for Medical Education, Fujita Health University of MedicineDepartment of Respiratory Diseases, Second Hospital for Medical Education, Fujita Health University of MedicineDepartment of Respiratory Diseases, Second Hospital for Medical Education, Fujita Health University of MedicineDepartment of Respiratory Diseases, Second Hospital for Medical Education, Fujita Health University of MedicineDepartment of Respiratory Diseases, Second Hospital for Medical Education, Fujita Health University of MedicineOBJECTIVE. This study evaluated the effects of ebastine on serum eosinophil cationic protein (ECP) levels in patients with bronchial asthma. PATIENTS. Twenty patients with bronchial asthma and low efficiency of current therapy (11 patients with atopic disease and 9 with non-atopic disease) were enrolled in the study. METHODS. In an open-label design, all patients received ebastine 10 mg/day for 4 weeks and serum ECP levels, peripheral blood eosinophil counts, morning peak expiratory flow rate (PEFR) and thresholds for airway hyper-responsiveness (Dmin in asthgraphy) were determined before and after treatment. RESULTS. Serum ECP levels and peripheral blood eosinophil counts were significantly decreased. No significant change was found in the non-atopic patients, while the serum ECP level was significantly (phttps://www.med-sovet.pro/jour/article/view/1144бронхиальная астмакатионный белок эозинофиловэбастинbronchial asthmaeosinophil cationic proteinebastine
spellingShingle T. Horiguchi
S. Tachikawa
J. . Kasahara
Y. . Sasaki
M. . Hirose
M. . Shiga
R. Kondo
J. Miyazaki
M. . Sugiyama
Effect of ebastine on serum eosinophil cationic protein levels in patients with bronchial asthma
Медицинский совет
бронхиальная астма
катионный белок эозинофилов
эбастин
bronchial asthma
eosinophil cationic protein
ebastine
title Effect of ebastine on serum eosinophil cationic protein levels in patients with bronchial asthma
title_full Effect of ebastine on serum eosinophil cationic protein levels in patients with bronchial asthma
title_fullStr Effect of ebastine on serum eosinophil cationic protein levels in patients with bronchial asthma
title_full_unstemmed Effect of ebastine on serum eosinophil cationic protein levels in patients with bronchial asthma
title_short Effect of ebastine on serum eosinophil cationic protein levels in patients with bronchial asthma
title_sort effect of ebastine on serum eosinophil cationic protein levels in patients with bronchial asthma
topic бронхиальная астма
катионный белок эозинофилов
эбастин
bronchial asthma
eosinophil cationic protein
ebastine
url https://www.med-sovet.pro/jour/article/view/1144
work_keys_str_mv AT thoriguchi effectofebastineonserumeosinophilcationicproteinlevelsinpatientswithbronchialasthma
AT stachikawa effectofebastineonserumeosinophilcationicproteinlevelsinpatientswithbronchialasthma
AT jkasahara effectofebastineonserumeosinophilcationicproteinlevelsinpatientswithbronchialasthma
AT ysasaki effectofebastineonserumeosinophilcationicproteinlevelsinpatientswithbronchialasthma
AT mhirose effectofebastineonserumeosinophilcationicproteinlevelsinpatientswithbronchialasthma
AT mshiga effectofebastineonserumeosinophilcationicproteinlevelsinpatientswithbronchialasthma
AT rkondo effectofebastineonserumeosinophilcationicproteinlevelsinpatientswithbronchialasthma
AT jmiyazaki effectofebastineonserumeosinophilcationicproteinlevelsinpatientswithbronchialasthma
AT msugiyama effectofebastineonserumeosinophilcationicproteinlevelsinpatientswithbronchialasthma